Skip to main content
Log in

Inhibition of the accumulation of macrophages and the generation of macrophage chemotactic activity by dexamethasone in concanavalin A-induced peritonitis of mice

  • Immunosuppression and Inflammations
  • Published:
Agents and Actions Aims and scope Submit manuscript

Abstract

A delayed-type inflammatory response was evoked in mice using concanavalin A (Con A) as a stimulus, and the effect of various anti-inflammatory agents on the inflammations was examined. The intraperitoneal injection of Con A in the mouse resulted in the marked accumulation of leukocytes, especially macrophages, in the peritoneal cavity between 16 and 48 hr after the injection. Prior to the accumulation of macrophages, the chemotactic activity for macrophages appeared in the peritoneal fluid, and was associated with protein(s) in the molecular weight range from 10000 to 100000 daltons. When the effect of various agents on Con A-induced peritonitis was examined, neither anticomplementary agents (FUT-175 and K-76 COONa), bromophenacyl bromide, nordihydroguaiaretic acid nor indomethacin affected the generation of chemotactic activity and the accumulation of macrophages, suggesting that C5a, prostaglandins and leukotriene B4 are hardly involved in the Con A-induced macrophage accumulation. On the other hand, dexamethasone suppressed both the generation of chemotactic activity and the accumulation of macrophages. Taking into consideration the observation that the synthesis of macrophage chemotactic factors by mitogen-stimulated lymphocytes is inhibited by glucocorticoids these results suggest that the macrophage chemotactic lymphokines might be involved in the accumulation of macrophages in Con A-induced peritonitis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Abbreviations

Con A:

concanavalin A

NDGA:

nordihydroguaiaretic acid

BPB:

bromophenacyl bromide

DMSO:

dimethyl sulfoxide

PBS:

phosphate-buffered saline

References

  1. T. Yamashita, Y. Ishibashi, I. Nagaoka, K. Kasuya, K. Masuda, H. Warabi and Y. Shiokawa.Studies on glycogen-induced inflammation of mice. Dynamics of inflammatory responses and influence of anti-inflammatory drugs and protease inhibitors. Inflammation6, 87–101 (1982).

    Article  PubMed  Google Scholar 

  2. H. Z. Movat,The Inflammatory Reaction, pp. 311–336, Elsevier, Amsterdam 1985.

    Google Scholar 

  3. R. Snyderman, M. C. Pike, B.L. Blaylock and P. Weinstein,Effects of neoplasms on inflammation: depression of macrophage accumulation after tumor implantation. J. Immunol.116, 585–589 (1976).

    PubMed  Google Scholar 

  4. I. Nagaoka, Y. Ishibashi and T. Yamashita,Studies on phytohemagglutinin-induced peritonitis of mice: dynamics of inflammatory responses and influence of anticomplementary agents and anti-inflammatory drugs. Int. J. Tiss. React.IX, 179–188 (1987).

    Google Scholar 

  5. T. Yamashita, N. Imaizumi and S. Yuasa,Effect of endocellular cryoprotectant upon polymorphonuclear neutrophil function during storage at low temperature. Cryobiology16, 112–117 (1979).

    Article  PubMed  Google Scholar 

  6. I. Nagaoka and T. Yamashita,Comparative studies on the leucine aminopeptidase activity of different types of leukocytes. Comp. Biochem. Physiol.79 B, 147–151 (1984).

    Google Scholar 

  7. H. Z. Movat,The Inflammatory Reaction, pp. 203–257 Elsevier, Amsterdam 1985.

    Google Scholar 

  8. P. A. Ward, T. E. Hugli and D. E. Chenoweth,Complement and chemotaxis. InChemical Messenger of the Inflammatory Process. (Ed. J. C. Houck) pp. 153–178, Elsevier, Amsterdam 1979.

    Google Scholar 

  9. S. H. Ferreira,Prostaglandins. InChemical Messengers of the Inflammatory Process. (Ed. J. C. Houck) pp. 113–151, Elsevier, Amsterdam 1979.

    Google Scholar 

  10. S. Fujii and Y. Hitomi,New synthetic inhibitors of Ctr, C1 esterase, thrombin, plasmin, kallikrein and trypsin. Biochim. Biophys. Acta661, 342–345 (1981).

    PubMed  Google Scholar 

  11. K. Hong, T. Kinoshita, W. Miyazaki, T. Izawa and K. Inoue,An anti-complementary agent, K-76 monocarboxylic acid: its site and mechanism of inhibition of the complement activation cascade. J. Immunol.122, 2418–2423 (1979).

    PubMed  Google Scholar 

  12. G. J. Blackwell and R. J. Flower,Inhibition of phospholipase. Br. Med. Bull.39, 260–264 (1983).

    PubMed  Google Scholar 

  13. G. A. Higgs and J. R. Vane,Inhibition of cyclo-oxygenase and lipoxygenase. Br. Med. Bull.39, 265–270 (1983).

    PubMed  Google Scholar 

  14. R. Snyderman, M. C. Pike, D. McCarley and L. Lang,Quantification of mouse macrophage chemotaxis in vitro: role of C5 for the production of chemotactic activity. Infect. Immun.11, 488–492 (1975).

    PubMed  Google Scholar 

  15. M. J. H. Smith, A. W. Ford-Hutchinson and M. A. Bray,Leukotriene B: a potential mediator of inflammation. J. Pharm. Pharmacol.32, 517–518 (1980).

    PubMed  Google Scholar 

  16. R. M. J. Palmer, R. J. Stepney, G. A. Higgs and K. E. Eakins,Chemokinetic activity of aracidonic acid lipoxygenase products on leucocytes of different species. Prostaglandins20, 411–418 (1980).

    PubMed  Google Scholar 

  17. M. A. Bray,The pharmacology and pathophysiology of leukotriene B 4. Br. Med. Bull.39, 249–254 (1983).

    PubMed  Google Scholar 

  18. P. A. Ward, H. G. Remold and J. R. David,Leukotactic factor produced by sensitized lymphocytes. Science163, 1079–1081 (1969).

    PubMed  Google Scholar 

  19. R. Snyderman, L. C. Altman, M. S. Hausman and S. E. Mergenhagen,Human mononuclear leukocyte chemotaxis: a quantitative assay for humoral and cellular chemotactic factors. J. Immunol.108, 857–860 (1972).

    PubMed  Google Scholar 

  20. L. C. Altman R. Snyderman, J. J. Oppenheim and S. E. Mergenhagen,A human mononuclear leukocyte chemotactic factor: characterization, specificity and kinetics of production by homologous leukocytes. J. Immunol.110, 801–810 (1973).

    PubMed  Google Scholar 

  21. D. A. Boetcher and M. S. Meltzer,Mouse mononuclear cell chemotaxis: description of system. J. Natl. Cancer Inst.54, 795–799 (1975).

    PubMed  Google Scholar 

  22. H. Rühl,Effects of L-asparaginase and hydrocortisone on human lymphocyte transformation and production of a mononuclear leucocyte chemotactic factor in vitro. Immunology26, 989–994 (1974).

    PubMed  Google Scholar 

  23. S. M. Wahl, L. C. Altman and D. L. Rosenstreich,Inhibition of in vitro lymphokine synthesis by glucocorticosteroids. J. Immunol.115, 476–481 (1975).

    PubMed  Google Scholar 

  24. R. E. Rocklin and J. R. David,Studies on the characterization of mediators produced by antigen-stimulated human lymphocytes. Fed. Proc.30, 395 (1971).

    Google Scholar 

  25. E. J. Leonard and M. S. Meltzer,Characterization of mouse lymphocyte-derived chemotactic factor. Cell Immunol.26, 200–210 (1976).

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nagaoka, I., Kaneko, H. & Yamashita, T. Inhibition of the accumulation of macrophages and the generation of macrophage chemotactic activity by dexamethasone in concanavalin A-induced peritonitis of mice. Agents and Actions 25, 156–163 (1988). https://doi.org/10.1007/BF01969107

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01969107

Keywords

Navigation